Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$2.48B |
| 2 |
Wells Fargo
WFC
|
+$2.4B |
| 3 |
NVIDIA
NVDA
|
+$2.03B |
| 4 |
American Express
AXP
|
+$948M |
| 5 |
Amazon
AMZN
|
+$855M |
Top Sells
| 1 |
Pfizer
PFE
|
+$1.71B |
| 2 |
Chubb
CB
|
+$1.57B |
| 3 |
ConocoPhillips
COP
|
+$1.49B |
| 4 |
Microsoft
MSFT
|
+$1.37B |
| 5 |
Advanced Micro Devices
AMD
|
+$1.15B |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Healthcare | 20.37% |
| 3 | Financials | 14.37% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Krystal Biotech
KRYS
$4.11B
| $1.66M | ﹤0.01% |
+9,308
| New | +$1.66M |
|
|
WBA
1477
DELISTED
Walgreens Boots Alliance
WBA
| $1.66M | ﹤0.01% |
76,307
+18,046
| +31% | +$391K |
|
1478
Keysight
KEYS
$29B
| $1.65M | ﹤0.01% |
10,569
+1,393
| +15% | +$218K |
|
1479
W.P. Carey
WPC
$14.7B
| $1.65M | ﹤0.01% |
29,205
+1,731
| +6% | +$97.7K |
|
1480
Lexicon Pharmaceuticals
LXRX
$403M
| $1.65M | ﹤0.01% |
+686,418
| New | +$1.65M |
|
1481
Astria Therapeutics
ATXS
$404M
| $1.63M | ﹤0.01% |
+116,057
| New | +$1.63M |
|
1482
Iovance Biotherapeutics
IOVA
$876M
| $1.63M | ﹤0.01% |
110,219
-44,926
| -29% | -$666K |
|
1483
Fulcrum Therapeutics
FULC
$395M
| $1.63M | ﹤0.01% |
+172,660
| New | +$1.63M |
|
1484
Clorox
CLX
$15.3B
| $1.63M | ﹤0.01% |
10,631
+8,402
| +377% | +$1.29M |
|
1485
C4 Therapeutics
CCCC
$193M
| $1.61M | ﹤0.01% |
+197,109
| New | +$1.61M |
|
|
VBNK
1486
VersaBank
VBNK
$387M
| $1.61M | ﹤0.01% |
151,883
+27,600
| +22% | +$293K |
|
1487
Starwood Property Trust
STWD
$7.57B
| $1.61M | ﹤0.01% |
79,120
+12,858
| +19% | +$261K |
|
1488
Altimmune
ALT
$330M
| $1.6M | ﹤0.01% |
+156,914
| New | +$1.6M |
|
1489
AES
AES
$9.09B
| $1.59M | ﹤0.01% |
88,830
-8,303,868
| -99% | -$149M |
|
1490
Invitation Homes
INVH
$18.5B
| $1.59M | ﹤0.01% |
44,560
+2,219
| +5% | +$79K |
|
1491
Thomson Reuters
TRI
$79.1B
| $1.55M | ﹤0.01% |
9,970
+6,722
| +207% | +$1.05M |
|
1492
Biohaven
BHVN
$1.53B
| $1.55M | ﹤0.01% |
28,277
+14,411
| +104% | +$788K |
|
1493
Oric Pharmaceuticals
ORIC
$1.07B
| $1.54M | ﹤0.01% |
111,973
+39,576
| +55% | +$544K |
|
1494
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$10.6B
| $1.54M | ﹤0.01% |
+47,000
| New | +$1.54M |
|
1495
Biomea Fusion
BMEA
$108M
| $1.53M | ﹤0.01% |
102,534
+16,998
| +20% | +$254K |
|
1496
Coastal Financial
CCB
$1.66B
| $1.52M | ﹤0.01% |
39,120
-8,829
| -18% | -$343K |
|
1497
Teradata
TDC
$1.97B
| $1.51M | ﹤0.01% |
39,145
+14,037
| +56% | +$543K |
|
1498
Banco de Chile
BCH
$15.2B
| $1.49M | ﹤0.01% |
66,970
-213,746
| -76% | -$4.76M |
|
1499
CNA Financial
CNA
$12.9B
| $1.49M | ﹤0.01% |
32,713
+7,769
| +31% | +$353K |
|
1500
Loews
L
$19.9B
| $1.49M | ﹤0.01% |
18,975
-1,551
| -8% | -$121K |
|